AMRI Announces Five-Year Extension of API Supply Agreement with Shire
News Oct 23, 2012
AMRI has announced that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing Inc., whose parent company, Shire plc, is a global company that focuses its business on behavioral health, gastro intestinal diseases, rare diseases and regenerative medicine.
The agreement extends a previously existing agreement between the two companies. The terms of the agreement are confidential.
“We are pleased to extend this agreement with Shire,” said Thomas E. D’Ambra, Ph.D., Chairman, President and Chief Executive Officer of AMRI.
D’Ambra continued, “Our partnership lays the groundwork for AMRI to be considered by Shire for future development and manufacturing opportunities.”
Concept Life Sciences appoints New Group Programme Manager and US Head of SalesNews
Key leadership appointments support integration of the Group and expansion in the US market.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE